GlassScriptPhysician profile
Richard A Michner
NPI 1376527291
$430.26
in general payments reported to CMS, 2019-2025
14 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $344 · 2020: $26.52 · 2021: $43.06 · 2022: $16.96.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $176.32 | 2019-2021 | |
| Covidien LP | $33.57 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $33.36 | 2019-2020 | |
| Therapeuticsmd, INC. | $29.43 | 2019 | |
| Merck Sharp & Dohme LLC | $26.50 | 2019-2020 | |
| Ethicon US, LLC | $18.33 | 2019 | |
| Organon LLC | $16.96 | 2022 | |
| Medtronic, INC. | $16.32 | 2021 | |
| Sage Therapeutics, LLC | $15.38 | 2019 | |
| Lupin INC. | $15.00 | 2019 | |
| Evofem Biosciences, INC. | $13.27 | 2021 | |
| Millicent US INC | $12.57 | 2019 | |
| Daiichi Sankyo INC. | $12.27 | 2019 | |
| Boston Scientific Corporation | $10.98 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Richard Michner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.